Susquehanna Fundamental Investments’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,260
| Closed | -$144K | – | 1123 |
|
|
2024
Q4 | $144K | Buy |
+65,260
| New | +$144K | ﹤0.01% | 1026 |
|
|
2024
Q2 | – | Sell |
-166,457
| Closed | -$446K | – | 955 |
|
|
2024
Q1 | $446K | Buy |
+166,457
| New | +$446K | 0.02% | 489 |
|
|
2023
Q3 | – | Sell |
-41,809
| Closed | -$58.1K | – | 444 |
|
|
2023
Q2 | $58.1K | Hold |
41,809
| – | – | ﹤0.01% | 619 |
|
|
2023
Q1 | $66.5K | Sell |
41,809
-28,907
| -41% | -$46K | ﹤0.01% | 916 |
|
|
2022
Q4 | $441K | Buy |
+70,716
| New | +$441K | 0.01% | 904 |
|
|
2021
Q3 | – | Sell |
-50,792
| Closed | -$1.07M | – | 1750 |
|
|
2021
Q2 | $1.07M | Buy |
50,792
+42,133
| +487% | +$891K | 0.02% | 825 |
|
|
2021
Q1 | $243K | Buy |
+8,659
| New | +$243K | ﹤0.01% | 1349 |
|